1. Cost–utility of sofosbuvir/velpatasvir versus other direct-acting antivirals for chronic hepatitis C genotype 1b infection in China. Issue 8 (20th August 2020) Authors: Yun, Haoya; Zhao, Guoqiang; Sun, Xiaojie; Shi, Lizheng Journal: BMJ open Issue: Volume 10:Issue 8(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗